Kazia Therapeutics Limited (KZA) is an oncology-focused biotechnology company. KZA is focused on the development of novel anti-cancer drugs based on two proprietary drug technologies known as Super-benzopyrans and Anti-tropomyosins. KZA is headquartered in Sydney, Australia, with an office in New Haven, Connecticut in the US.
Kazia Therapeutics Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.kaziatherapeutics.com.
You can also check out dividend history for similar stocks in the same sector as follows:
KZA Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found